The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Incidence of and Outcomes Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention
Abstract
CONTEXT: The incidence and timing of sustained ventricular tachycardia or fibrillation (VT/VF) and its impact on outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) are poorly understood. OBJECTIVE: To evaluate the association of sustained VT/VF and its timing on the outcomes of patients presenting for primary PCI-an aim not prespecified in the APEX AMI trial. DESIGN, SETTING, AND PATIENTS: We studied 5745 STEMI patients presenting for primary PCI at 296 hospitals in 17 countries between July 13, 2004, and May 11, 2006, from the APEX AMI trial. We categorized them into 4 groups: no VT/VF; VT/VF any time; early VT/VF, before the end of cardiac catheterization; and late VT/VF, after the end of cardiac catheterization. MAIN OUTCOME MEASURE: Ninety-day total mortality. RESULTS: VT/VF occurred in 329 STEMI patients (5.7%) presenting for primary PCI. The majority of these occurred before the end of catheterization (n = 205, 64%), and 90% occurred within 48 hours of presentation with symptoms of STEMI. Clinical outcomes were worse in patients with vs those without VT/VF (90-day mortality, 23.2% vs 3.6%; adjusted HR, 3.63; 95% CI, 2.59-5.09), and outcomes were worse if the VT/VF occurred late instead of early (90-day mortality for early VT/VF, 17.2% [adjusted HR, 2.34; 95% CI, 1.44-3.80]; for late VT/VF, 33.3% [adjusted HR, 5.59; 95% CI, 3.71-8.43]; for no VT/VF, 3.6% [referent]). In multivariate analyses, factors associated with early VT/VF included pre-PCI thrombolysis in MI (TIMI) flow grade 0 (HR, 2.94; 95% CI, 1.93-4.47), inferior infarction (HR, 2.16; 95% CI, 1.58-2.93), total baseline ST deviation (HR, 1.39; 95% CI, 1.19-1.63), creatinine clearance (HR, 0.88; 95% CI, 0.83-0.94), Killip class greater than I (HR, 1.88; 95% CI, 1.29-2.76), baseline systolic blood pressure (HR, 0.92; 95% CI, 0.87-0.98), body weight (HR, 1.16; 95% CI, 1.04-1.29), and baseline heart rate greater than 70/min (HR, 1.10; 95% CI, 1.01-1.20) (c index, 0.75). Factors related to late VT/VF were systolic blood pressure (HR, 0.83; 95% CI, 0.76-0.91), ST resolution less than 70% (HR, 3.17; 95% CI, 1.60-6.28), baseline heart rate greater than 70/min (HR, 1.20; 95% CI, 1.08-1.33), total baseline ST deviation (HR, 1.43; 95% CI, 1.14-1.79), post-PCI TIMI flow less than grade 3 (HR, 2.09; 95% CI, 1.24-3.52), pre-PCI TIMI flow grade 0 (HR, 2.12; 95% CI, 1.20-3.75), and beta-blockers less than 24 hours (HR, 0.52; 95% CI, 0.32-0.85) (c index, 0.74). CONCLUSIONS: In this study, occurrence of VT/VF before or after the end of cardiac catheterization in patients presenting for primary PCI was associated with increased 90-day mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
GRUPPOITALIANOPERLOSTUDIODELL (1986) · The Lancet · doi:10.1016/s0140-6736(86)92368-8 · Cited by 2,440
Prognosis and Outcomes of Patients With Community-Acquired Pneumonia: A Meta-analysis
Fine, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03530260048030 · Cited by 1,310
Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction
Montalescot, G., Barragan, P., Wittenberg, O., Ecollan, P., Elhadad, S., Villain, P., Boulenc, J.-M., Morice, M.-C., Maillard, L., Pansiéri, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442503 · Cited by 1,186
TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
Wilcox, R. G., Olsson, C. G., Skene, A. M., Von Der Lippe, G., Jensen, G., Hampton, J. R., & For The Asset Study Group (1988) · The Lancet · doi:10.1016/s0140-6736(88)92656-6 · Cited by 1,153
Thrombus Aspiration during Primary Percutaneous Coronary Intervention
Svilaas, T., Vlaar, P. J., van der Horst, I. C., Diercks, G. F. H., de Smet, B. J. G. L., van den Heuvel, A. F. M., Anthonio, R. L., Jessurun, G. A., Tan, E.-S., Suurmeijer, A. J. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706416 · Cited by 1,071
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252101 · Cited by 1,051
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
Lexau, C. A. (2005) · JAMA · doi:10.1001/jama.294.16.2043 · Cited by 671
Rezkalla, S. H., & Kloner, R. A. (2002) · Circulation · doi:10.1161/hc0502.102867 · Cited by 621
THE MIAMI TRIAL RESEARCH GROUP (1985) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061845 · Cited by 614
Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
Jackson, L. A., Neuzil, K. M., Yu, O., Benson, P., Barlow, W. E., Adams, A. L., Hanson, C. A., Mahoney, L. D., Shay, D. K., & Thompson, W. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022678 · Cited by 608
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review
Jefferson, T., Rivetti, D., Rivetti, A., Rudin, M., Di Pietrantonj, C., & Demicheli, V (2005) · The Lancet · doi:10.1016/s0140-6736(05)67339-4 · Cited by 601
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
MacLeod, C. M., Hodges, R. G., Heidelberger, M., & Bernhard, W. G. (1945) · Journal of Experimental Medicine · doi:10.1084/jem.82.6.445 · Cited by 518
French, N., Nakiyingi, J., Carpenter, L., Lugada, E., Watera, C., Moi, K., Moore, M., Antvelink, D., Mulder, D., Janoff, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02377-1 · Cited by 461
7. Prevention of Pneumococcal Pneumonia by Vaccination
Austrian, R., Douglas, R. M., Schiffman, G., Coetzee, A. M., Koornhof, H. J., Hayden-Smith, S., & Reid, R. D. W. (1985) · Life with the Pneumococcus · doi:10.9783/9781512800135-009 · Cited by 401
Adherence to Treatment and Health Outcomes
Horwitz, R. I. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.16.1863 · Cited by 400
Efficacy of Pneumococcal Vaccine in High-Risk Patients
Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., Baltch, A. L., Geiseler, P. J., Nadler, J., Richmond, A. S., Smith, R. P., Schiffman, G., Shepard, D. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611203152104 · Cited by 395
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub2 · Cited by 387
Örtqvist, Å., Hedlund, J., Burman, L.-Å., Elbel, E., Höfer, M., Leinonen, M., Lindblad, I., Sundelöf, B., & Kalin, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07358-3 · Cited by 376
Efficacy of Pneumococcal Vaccination in Adults: A Meta-analysis of Randomized Controlled Trials
Fine, M. J. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420230051007 · Cited by 370
Protective Efficacy of Pneumococcal Polysaccharide Vaccines
Smit, P. (1977) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1977.03280250039019 · Cited by 350
The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly
SIMS, R. V., STEINMANN, W. C., MCCONVILLE, J. H., KING, L. R., ZWICK, W. C., & SCHWARTZ, J. S. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-653 · Cited by 317
Bacteriology of Hospital-Acquired Pneumonia
Bartlett, J. G. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.5.868 · Cited by 268
Clinical efficacy of anti-pneumococcal vaccination in patients with COPD
Alfageme, I. (2006) · Thorax · doi:10.1136/thx.2005.043323 · Cited by 233
Clinical Efficacy of Pneumococcal Vaccine in the Elderly
Koivula, I., Stén, M., Leinonen, M., & Mäkelä, P. H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00149-6 · Cited by 217
Sustained Ventricular Arrhythmias in Patients Receiving Thrombolytic Therapy: Incidence and Outcomes
Newby, K. H., Thompson, T., Stebbins, A., Topol, E. J., Califf, R. M., & Natale, A. (1998) · Circulation · doi:10.1161/01.cir.98.23.2567 · Cited by 213
Schneider, E. C., Cleary, P. D., Zaslavsky, A. M., & Epstein, A. M. (2001) · JAMA · doi:10.1001/jama.286.12.1455 · Cited by 203
Melegaro, A., & Edmunds, W. J. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000024701.94769.98 · Cited by 185
IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE
Riley, I. D., Andrews, M., Howard, R., Tarr, P. I., Pfeiffer, M., Challands, P., Jennison, G., & Douglas, R. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92552-1 · Cited by 184
Cornu, C., Yzèbe, D., Léophonte, P., Gaillat, J., Boissel, J. P., & Cucherat, M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00217-1 · Cited by 166
Honkanen, P. O., Keistinen, T., Miettinen, L., Herva, E., Sankilampi, U., Läärä, E., Leinonen, M., Kivelä, S.-L., & Helena Mäkelä, P. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00069-9 · Cited by 161
Mehta, R. H., Harjai, K. J., Grines, L. L., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.072 · Cited by 147
Self-citationMagnitude, Duration, Quality, and Function of Pneumococcal Vaccine Responses in Elderly Adults
Rubins, J. B., Puri, A. K. G., Loch, J., Charboneau, D., MacDonald, R., Opstad, N., & Janoff, E. N. (1998) · The Journal of Infectious Diseases · doi:10.1086/515644 · Cited by 141
Mangtani, P., Cutts, F. T., & Hall, A. J. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00514-0 · Cited by 139
Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults
Watson, L. C., Wilson, B. J., & Waugh, N. R. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00112-3 · Cited by 131
Granger, R. H., Walters, J. A., Poole, P., Lasserson, T. J., Mangtani, P., Cates, C. J., & Wood-Baker, R. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001390.pub2 · Cited by 130
Early Sustained Ventricular Arrhythmias Complicating Acute Myocardial Infarction
Piccini, J. P., Berger, J. S., & Brown, D. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.04.024 · Cited by 128
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
Moore, R. A., Wiffen, P. J., & Lipsky, B. A. (2000) · BMC Family Practice · doi:10.1186/1471-2296-1-1 · Cited by 127
Chalmers, I. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.5.1156 · Cited by 126
Kaufman, P. (1947) · Archives of Internal Medicine · doi:10.1001/archinte.1947.00220110058004 · Cited by 123
Pneumococcal vaccines for sickle cell disease
Davies, E. G., Hirst, C., Lottenberg, R., & Dower, N. A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003885.pub2 · Cited by 122
Conaty, S. J., Watson, L. C., Dinnes, J., & Waugh, N. R. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.08.050 · Cited by 118
Anti-pneumococcal antibody response in normal subjects: A meta-analysis
Go, E., & Ballas, Z. K. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70244-0 · Cited by 117
[Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].
GAILLAT, J., Zmirou‐Navier, D., Mallaret, M., Rouhan, D., Bru, J. P., Stahl, J. ‐., Delormas, P., & Micoud, M. (1985) · PubMed · Cited by 115
Fortnightly Review: The pneumococcal problem
Obaro, S., Monteil, M., & Henderson, D. C. (1996) · BMJ · doi:10.1136/bmj.312.7045.1521 · Cited by 106
Clinical effectiveness of pneumococcal vaccine. Meta-analysis.
Hutchison, B. G., Oxman, A., Shannon, H. S., Lloyd, S., Altmayer, C. A., & Thomas, K. (1999) · PubMed Central · Cited by 104
Davis, A. L., Aranda, C. P., Schiffman, G., & Christianson, L. C. (1987) · CHEST Journal · doi:10.1378/chest.92.2.204 · Cited by 103
Estimating the effects of misclassification
Mertens, T. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92820-j · Cited by 90
Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.
Leech, J., Gervais, A., & Ruben, F. L. (1987) · Europe PMC (PubMed Central) · Cited by 88
Pneumococcal vaccination during pregnancy for preventing infant infection
Chaithongwongwatthana, S., Yamasmit, W., Limpongsanurak, S., Lumbiganon, P., & Tolosa, J. E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004903.pub4 · Cited by 83
Pneumococcal vaccines for children and adults with bronchiectasis
Chang, C. C., Singleton, R. J., Morris, P. S., & Chang, A. B. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006316.pub3 · Cited by 83
Volpi, A., Cavalli, A., Santoro, E., & Tognoni, G. (1990) · Circulation · doi:10.1161/01.cir.82.4.1279 · Cited by 68
Does Skepticism Towards Medical Care Predict Mortality?
Fiscella, K. A., Franks, P. J., Clancy, C. M., Doescher, M. P., & Banthin, J. S. (1999) · Medical Care · doi:10.1097/00005650-199904000-00010 · Cited by 67
Racial and ethnic disparities in influenza vaccination among elderly adults
Rangel, M. C., Schoenbach, V. J., Weigle, K. A., Hogan, V. K., Strauss, R. P., & Bangdiwala, S. I. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0097.x · Cited by 63
Gressin, V., Louvard, Y., Pezzano, M., & Lardoux, H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91295-f · Cited by 58
Pneumococcal vaccine for asthma
Sheikh, A., Alves, B., & Dhami, S. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002165 · Cited by 57
Armstrong, P. W., Adams, P. X., Al‐Khalidi, H. R., Hamm, C. W., Holmes, D. R., O’Neill, W. W., Todaro, T. G., Vahanian, A. S., de Werf, F. V., & Granger, C. B. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.015 · Cited by 52
Steentoft, J., Konradsen, H. B., HILSKOV, J., Gislason, G., & Andersen, J. R. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.020 · Cited by 51
Wagner, C., Popp, W., Posch, M., Vlasich, C., & Rosenberger-Spitzy, A. (2003) · Gerontology · doi:10.1159/000070405 · Cited by 51
Mehta, R. H., Califf, R. M., Garg, J., White, H. D., de Werf, F. V., Armstrong, P. W., Pieper, K. S., Topol, E. J., & Granger, C. B. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl329 · Cited by 49
Self-citationPlacebo controlled pneumococcal immunization in patients with bronchogenic carcinoma
Klastersky, J., Mommen, P., Cantraine, F. R. L., & Safary, A. (1986) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(86)90367-6 · Cited by 46
Majidi, M., Kosinski, A. S., Al‐Khatib, S. M., Lemmert, M. E., Smolders, L., van Weert, A. W. M., Reiber, J. H. C., Tzivoni, D., Bär, F. W. H. M., Wellens, H. J. J., et al. (2008) · EP Europace · doi:10.1093/europace/eun123 · Cited by 37
Gibson, C. M., Pride, Y. B., Buros, J. L., Lord, E. E., Shui, A. M., Murphy, S. A., Pinto, D. S., ZIMETBAUM, P. J., Sabatine, M. S., Cannon, C. P., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.061 · Cited by 34
Gerber, S., Tallon, D., Trelle, S., Schneider, M., Jüni, P., & Egger, M. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.10.022 · Cited by 30
Noakes, K., Pebody, R. G., Gungabissoon, U., Stowe, J., & Miller, E. (2006) · Journal of Public Health · doi:10.1093/pubmed/fdl017 · Cited by 27
Smoothing Spline‐Based Score Tests for Proportional Hazards Models
Lin, J., Zhang, D., & Davidian, M. (2006) · Biometrics · doi:10.1111/j.1541-0420.2005.00521.x · Cited by 26
Fedson, D. S. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00604-2 · Cited by 15
Cited by
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
Metadata
- Authors
- Mehta, R. H.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2009-05-06
- Volume
- 301
- Issue
- 17
- Pages
- 1779
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2091116312
- Cited by
- 293
- References
- 75
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.